Brainlab has announced the acquisition of Dr. Langer Medical GmbH. Based in Waldkrich, Germany, the family-owned company specializes in the development of intraoperative neuromonitoring solutions and related equipment for surgical interventions. The overarching and unified goal of Brainlab and Dr. Langer Medical is to create synergies for the “digital surgery” ecosystem as well as align entrepreneurial activities and innovation potential. Dr. Langer Medical GmbH will continue to operate as an independent company within the Brainlab Group.
“Brainlab has been interested in the potential of digital integration in neuromonitoring for quite some time. Up until now, we were hesitant to pursue this technology due to the complexity of the available systems and their workflows,” said Stefan Vilsmeier, CEO and President of Brainlab. “The design and usability of Dr. Langer Medical GmbH’s approach to neuromonitoring serves as the perfect foundation to leverage the full potential of deep integration. Dr. Langer Medical’s solutions are all developed digitally and thereby fit perfectly with our strategy to gradually expand neuronavigation by integrating more critical data components.”
Dr. Langer Medical’s neuromonitoring solutions provide important information about the condition of affected nerves during surgical interventions. These solutions also enable medical staff preparing patients for surgery to visualize anatomical landmarks when attaching reference points. This allows the associated stimulation channels to be automatically assigned. While Dr. Langer Medical’s neuromonitoring system is already well established in thyroid and ENT surgery, it is only recently gaining traction in the field of cranial neurosurgery. This acquisition serves as a major growth opportunity for Brainlab to further differentiate its product portfolio. Working toward this goal, Brainlab and Dr. Langer Medical aim to integrate their technologies, provide end-to-end workflows for neurosurgery, spine surgery, abdominal and other surgical fields, and in this way, innovate in the field of neuromonitoring.
“Over the last 25 years, we have grown into a successful medium-sized company in intraoperative neuromonitoring and have been among the market leaders in this field for many years,” said Dr. Andreas Langer, Co-Founder and Co-Managing Director of Dr. Langer Medical GmbH.
Co-Founder and Co-Managing Director, Heike Langer added, “We are very proud of our employees and our innovative corporate culture. We share the same values, vision and way of thinking with Brainlab and know that we have found a perfect environment for our company. We are united by the goal of developing medical products of the highest quality for physicians and patients worldwide.”
With a strong focus on research and development, Dr. Langer Medical is well positioned to advance next-generation technologies such as pelvic monitoring or navigated stimulation probes. Brainlab will support Dr. Langer Medical with clinical and technical expertise as well as a customer base of more than 6,000 clinics around the world. To achieve the joint goals and accelerate development activities, Brainlab intends to invest additional resources in Dr. Langer Medical.